These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 26607380)

  • 1. Leukemia-Associated Cohesin Mutants Dominantly Enforce Stem Cell Programs and Impair Human Hematopoietic Progenitor Differentiation.
    Mazumdar C; Shen Y; Xavy S; Zhao F; Reinisch A; Li R; Corces MR; Flynn RA; Buenrostro JD; Chan SM; Thomas D; Koenig JL; Hong WJ; Chang HY; Majeti R
    Cell Stem Cell; 2015 Dec; 17(6):675-688. PubMed ID: 26607380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of mutations in the cohesin complex in acute myeloid leukemia.
    Mazumdar C; Majeti R
    Int J Hematol; 2017 Jan; 105(1):31-36. PubMed ID: 27796738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemia.
    Fischer A; Hernández-Rodríguez B; Mulet-Lazaro R; Nuetzel M; Hölzl F; van Herk S; Kavelaars FG; Stanewsky H; Ackermann U; Niang AH; Diaz N; Reuschel E; Strieder N; Hernández-López I; Valk PJM; Vaquerizas JM; Rehli M; Delwel R; Gebhard C
    Cell Rep; 2024 Aug; 43(8):114498. PubMed ID: 39084219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies.
    Sasca D; Yun H; Giotopoulos G; Szybinski J; Evan T; Wilson NK; Gerstung M; Gallipoli P; Green AR; Hills R; Russell N; Osborne CS; Papaemmanuil E; Göttgens B; Campbell P; Huntly BJP
    Blood; 2019 Dec; 134(24):2195-2208. PubMed ID: 31515253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.
    Diffner E; Beck D; Gudgin E; Thoms JA; Knezevic K; Pridans C; Foster S; Goode D; Lim WK; Boelen L; Metzeler KH; Micklem G; Bohlander SK; Buske C; Burnett A; Ottersbach K; Vassiliou GS; Olivier J; Wong JW; Göttgens B; Huntly BJ; Pimanda JE
    Blood; 2013 Mar; 121(12):2289-300. PubMed ID: 23327922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of inducible gene expression links cohesin to hematopoietic progenitor self-renewal and differentiation.
    Cuartero S; Weiss FD; Dharmalingam G; Guo Y; Ing-Simmons E; Masella S; Robles-Rebollo I; Xiao X; Wang YF; Barozzi I; Djeghloul D; Amano MT; Niskanen H; Petretto E; Dowell RD; Tachibana K; Kaikkonen MU; Nasmyth KA; Lenhard B; Natoli G; Fisher AG; Merkenschlager M
    Nat Immunol; 2018 Sep; 19(9):932-941. PubMed ID: 30127433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin organization in myelodysplastic syndrome.
    Xu JJ; Viny AD
    Exp Hematol; 2024 Jun; 134():104216. PubMed ID: 38582293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher-order orchestration of hematopoiesis: is cohesin a new player?
    Panigrahi AK; Pati D
    Exp Hematol; 2012 Dec; 40(12):967-73. PubMed ID: 23022223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of a GATA2-TAL1-ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells.
    Thoms JAI; Truong P; Subramanian S; Knezevic K; Harvey G; Huang Y; Seneviratne JA; Carter DR; Joshi S; Skhinas J; Chacon D; Shah A; de Jong I; Beck D; Göttgens B; Larsson J; Wong JWH; Zanini F; Pimanda JE
    Blood; 2021 Oct; 138(16):1441-1455. PubMed ID: 34075404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular pathogenesis of myelodysplastic syndromes with concurrent mutations in cohesin STAG2 and transcription factor RUNX1].
    Ochi Y
    Rinsho Ketsueki; 2021; 62(5):352-359. PubMed ID: 34108313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cohesin mutations in myeloid malignancies.
    Jann JC; Tothova Z
    Blood; 2021 Aug; 138(8):649-661. PubMed ID: 34157074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BET inhibition prevents aberrant RUNX1 and ERG transcription in STAG2 mutant leukaemia cells.
    Antony J; Gimenez G; Taylor T; Khatoon U; Day R; Morison IM; Horsfield JA
    J Mol Cell Biol; 2020 Jun; 12(5):397-399. PubMed ID: 31897485
    [No Abstract]   [Full Text] [Related]  

  • 13. Cohesin mutations alter DNA damage repair and chromatin structure and create therapeutic vulnerabilities in MDS/AML.
    Tothova Z; Valton AL; Gorelov RA; Vallurupalli M; Krill-Burger JM; Holmes A; Landers CC; Haydu JE; Malolepsza E; Hartigan C; Donahue M; Popova KD; Koochaki S; Venev SV; Rivera J; Chen E; Lage K; Schenone M; D'Andrea AD; Carr SA; Morgan EA; Dekker J; Ebert BL
    JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33351783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and Differentiation.
    Viny AD; Bowman RL; Liu Y; Lavallée VP; Eisman SE; Xiao W; Durham BH; Navitski A; Park J; Braunstein S; Alija B; Karzai A; Csete IS; Witkin M; Azizi E; Baslan T; Ott CJ; Pe'er D; Dekker J; Koche R; Levine RL
    Cell Stem Cell; 2019 Nov; 25(5):682-696.e8. PubMed ID: 31495782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cohesin Mutations in Myeloid Malignancies.
    Fisher JB; McNulty M; Burke MJ; Crispino JD; Rao S
    Trends Cancer; 2017 Apr; 3(4):282-293. PubMed ID: 28626802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification.
    Taoudi S; Bee T; Hilton A; Knezevic K; Scott J; Willson TA; Collin C; Thomas T; Voss AK; Kile BT; Alexander WS; Pimanda JE; Hilton DJ
    Genes Dev; 2011 Feb; 25(3):251-62. PubMed ID: 21245161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms.
    Mullenders J; Aranda-Orgilles B; Lhoumaud P; Keller M; Pae J; Wang K; Kayembe C; Rocha PP; Raviram R; Gong Y; Premsrirut PK; Tsirigos A; Bonneau R; Skok JA; Cimmino L; Hoehn D; Aifantis I
    J Exp Med; 2015 Oct; 212(11):1833-50. PubMed ID: 26438359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11.
    Hyde RK; Kamikubo Y; Anderson S; Kirby M; Alemu L; Zhao L; Liu PP
    Blood; 2010 Feb; 115(7):1433-43. PubMed ID: 20007544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cohesin Complex Is Necessary for Epidermal Progenitor Cell Function through Maintenance of Self-Renewal Genes.
    Noutsou M; Li J; Ling J; Jones J; Wang Y; Chen Y; Sen GL
    Cell Rep; 2017 Sep; 20(13):3005-3013. PubMed ID: 28954219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis.
    Viny AD; Ott CJ; Spitzer B; Rivas M; Meydan C; Papalexi E; Yelin D; Shank K; Reyes J; Chiu A; Romin Y; Boyko V; Thota S; Maciejewski JP; Melnick A; Bradner JE; Levine RL
    J Exp Med; 2015 Oct; 212(11):1819-32. PubMed ID: 26438361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.